Covid pill molnupiravir does not cut hospitalisation, the death rate in many vaccinated adults Subject: Science and Technology Context: Merck & Co Inc’s COVID antiviral molnupiravir speeds up recovery but does reduce the hospitalisation or death rate in higher-risk vaccinated adults, detailed data shows. Detail: The study, called PANORAMIC, compared the oral pill […]